Atlas Trials

Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy

Clinical trial NCT02435199 · WITHDRAWN

Trial details

NCT number
NCT02435199
Sponsor
Spinifex Pharmaceuticals Pty Ltd
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathies
Start date
2015-06-01
Primary completion
2016-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.